Diagnostic Imaging North America
January 2007
COVER STORY
By: H.A. Abella
DEPARTMENTS
Overread
Newsclips
Tech Watch
Agenda
Cardiovascular Imaging
By: Richard Spira, M.D.
Musculoskeletal
By: Nathalie Boutry, M.D., and Anne Cotten, M.D.
Practice Management
By: Frank James Lexa, M.D., M.B.A.
Neuroradiology
By: Ramon Palacios Bote, M.D., and Maria De Los Angeles Fernandez-Gil, M.D.
Perturbations
By: Eric Trefelner, M.D.
Special Sections
In Review
C. P. Kaiser
James Brice
Emily Hayes
John C. Hayes
H.A. Abella
Bradley M. Tipler, M.D.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.